|
ZDHHC13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.76729758500005E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.51369996934403E-09 |
| Normal-vs-Stage2 |
9.97889999965196E-07 |
| Normal-vs-Stage3 |
9.28749999129508E-09 |
| Normal-vs-Stage4 |
2.52180054616247E-10 |
| Stage1-vs-Stage2 |
3.330200E-01 |
| Stage1-vs-Stage3 |
4.130600E-01 |
| Stage1-vs-Stage4 |
2.983500E-02 |
| Stage2-vs-Stage3 |
7.273200E-01 |
| Stage2-vs-Stage4 |
4.823200E-01 |
| Stage3-vs-Stage4 |
2.453000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.79150036419651E-10 |
| Normal-vs-AfricanAmerican |
1.212410E-04 |
| Normal-vs-Asian |
5.8579999739905E-09 |
| Caucasian-vs-AfricanAmerican |
9.342800E-01 |
| Caucasian-vs-Asian |
2.256800E-01 |
| AfricanAmerican-vs-Asian |
3.914400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05849999987306E-07 |
| Normal-vs-Female |
2.76879630334292E-11 |
| Male-vs-Female |
4.522600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.77289999972963E-07 |
| Normal-vs-Age(41-60Yrs) |
6.06470429431738E-11 |
| Normal-vs-Age(61-80Yrs) |
1.44939948931722E-10 |
| Normal-vs-Age(81-100Yrs) |
1.296490E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.752300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.743900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.152600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.620200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.168000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.180600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.623200E-01 |
| Classical-VS-Follicular |
9.950800E-01 |
| Classical-VS-Other |
1.828810E-01 |
| Classical-VS-Normal |
1.77310000015751E-09 |
| Tall-VS-Follicular |
8.735000E-01 |
| Tall-VS-Other |
1.741420E-01 |
| Tall-VS-Normal |
1.56463999999579E-05 |
| Follicular-VS-Other |
7.559700E-02 |
| Follicular-VS-Normal |
3.18399999998942E-06 |
| Other-VS-Normal |
9.257600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7779999694767E-11 |
| Normal-vs-N1 |
9.17119999943594E-08 |
| N0-vs-N1 |
9.181800E-01 |
|
|
